Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Change In Receivables : $0.01 Mil (TTM As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Change In Receivables?

Cotinga Pharmaceuticals's change in receivables for the quarter that ended in Jan. 2020 was $-0.00 Mil. It means Cotinga Pharmaceuticals's Accounts Receivable increased by $0.00 Mil from Oct. 2019 to Jan. 2020 .

Cotinga Pharmaceuticals's change in receivables for the fiscal year that ended in Apr. 2019 was $0.05 Mil. It means Cotinga Pharmaceuticals's Accounts Receivable declined by $0.05 Mil from Apr. 2018 to Apr. 2019 .

Cotinga Pharmaceuticals's Accounts Receivable for the quarter that ended in Jan. 2020 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cotinga Pharmaceuticals's liquidation value for the three months ended in Jan. 2020 was $-3.64 Mil.

Cotinga Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Cotinga Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Change In Receivables Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Change In Receivables

Get a 7-Day Free Trial

-0.03

0.01

-0.01

0.01

0.05

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Change In Receivables	Get a 7-Day Free Trial															0.02	0.01	-	-	-

Cotinga Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

Cotinga Pharmaceuticals (OTCPK:COTQF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cotinga Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jan. 2020 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Cotinga Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Cotinga Pharmaceuticals's liquidation value for the quarter that ended in Jan. 2020 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.035	-	3.677	+	0.75 * 0	+	0.5 * 0
=	-3.64

Cotinga Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019